PHK
PRAX icon

Point72 Hong Kong’s Praxis Precision Medicines PRAX Stock Holding History

Point72 Hong Kong’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-340
Closed -$12K – 1303
2022
Q3 		$12K Buy
+340
New +$16.9K ﹤0.01% 1698
2022
Q2 		– Sell
-86
Closed -$13K – 2311
2022
Q1 		$13K Sell
86
-18
-17% -$3.7K ﹤0.01% 1576
2021
Q4 		$31K Buy
+104
New +$30.5K ﹤0.01% 1467
2021
Q2 		– Sell
-24
Closed -$12K – 2271
2021
Q1 		$12K Buy
+24
New +$17.1K ﹤0.01% 1568

Other funds holding PRAX

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 Hong Kong's PRAX Position: Q4 2022 in Review

Point72 Hong Kong sold out of Praxis Precision Medicines (PRAX) in Q4 2022, closing a stake of 340 shares — an estimated $12K sold.

Point72 Hong Kong first reported a position in PRAX in Q1 2021 and held it in 4 quarters. The position peaked at $31K in Q4 2021. 103 funds tracked by Wall St. Rank hold PRAX as of Q4 2022.

  • Point72 Hong Kong reported no remaining Praxis Precision Medicines position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 340 Praxis Precision Medicines shares in Q4 2022, an estimated $12K.
  • Point72 Hong Kong first reported a position in Praxis Precision Medicines in Q1 2021 and held it in 4 quarters.
  • Point72 Hong Kong's Praxis Precision Medicines position peaked at $31K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.